| Home > Zentren > Zentrum für Innere Medizin > I. Medizinische Klinik und Poliklinik > Publikationen > 2001
Benten D, Widjaja A, von Depka M, Flemming P, Trautwein C, Boker K, Vogel A, Rosenau J, Manns MP:
Autoimmune hepatitis associated with coagulation disorders and immunethyreopathy.
Z Gastroenterol 2001; 39: 837-40
http://www.ncbi.nlm.nih.gov/sites/entrez/11605152
Bläker M, de Weerth A, Matsui U, von Schrenck T:
Das Zollinger-Ellison-Syndrom.
Hamburger Ärzteblatt Heft 3/2001:126-130
Broering DC, Mueller L, Ganschow R, Kim JS, Achilles EG, Schafer H, Gundlach Fischer L, Sterneck M, Hillert C, Helmke K, Izbicki JR, Burdelski M, Rogiers X.:
Is there still a need for living-related liver transplantation in children?
Annals of Surgery 2001;234(6):713-721; discussion 721-722
http://www.ncbi.nlm.nih.gov/sites/entrez/11729377
Burda M, Günther S, Dandri M, Will H, Petersen J:
Structural and functional heterogeneity of naturally occuring HBV variants.
Review. Antiviral Research 2001; 52: 125-138
http://www.ncbi.nlm.nih.gov/sites/entrez/11672822
Dandri M, Burda MR, Iwanska A, Sommer G, Török E, Pollok JM, Rogiers X, Gupta S, Will H, Greten H, Petersen J:
Repopulation of mouse liver with human hepatocytes and in vivo infection with Hepatitis B virus.
Hepatology 2001; 33: 981-988
http://www.ncbi.nlm.nih.gov/sites/entrez/11283864
Dandri M, Burda MR, Török E, Pollok JM, Rogler CE, Will H, Petersen J:
Woodchuck hepatocytes remain permissive for hepatitis B virus infection and mouse liver repopulation after cryopreservation.
Hepatology 2001; 34: 824-33
http://www.ncbi.nlm.nih.gov/sites/entrez/11584382
Denzer U, Helmreich-Becker I, Galle PR, Lohse AW:
Sicherheit und Wertigkeit der Mini-Laparoskopie bei Hochrisikopatienten.
Z Gastroenterologie 2001; 39 (Suppl.1): 11-14
http://www.ncbi.nlm.nih.gov/sites/entrez/11216429
Denzer U, Helmreich-Becker I, Galle PR, Lohse AW:
Internistische Mini-Laparoskopie. Komplikationsarme Diagnostik auch beim Hochrisikopatienten.
Klinikarzt 2001; 30: 134-137
Denzer U, Lohse AW:
Technik der internistischen Laparoskopie: Mini-Optiken für eine minimalinvasive Diagnostik.
Klinikarzt 2001; 30: 131-133
Fischer L, Kalinina T, Rogiers X, Will H, Sterneck M.:
GLY145ARG mutation emerging under HBIG treatment in patients with recurrent HBV after liver transplantation strongly reduces viral secretion
Transplantation Proceedings 2001;33(7-8):3633-3636
http://www.ncbi.nlm.nih.gov/sites/entrez/11750543
Herkel J, Mimran A, Erez-Alon N, Kam N, Lohse AW, Märker-Hermann E, Rotter V, Cohen IR:
Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies.
J Autoimmunity 2001; 17: 63 - 69
http://www.ncbi.nlm.nih.gov/sites/entrez/11488638
Jaeckel E., Cornberg M., Wedemeyer H., Santantonio T., Mayer J., Zankel M., Pastore G., Dietrich M., Trautwein C., Manns M., for the German Acute Hepatitis C Therapy Group
Treatment of Acute Hepatitis C with Interferon Alfa-2b
NEJM 2001; 345: 1452-1457
http://www.ncbi.nlm.nih.gov/sites/entrez/11794193
Kalinina T, Riu A, Fischer L, Will H, Sterneck M.:
A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis
Hepatology, 2001;34(2):385-94
http://www.ncbi.nlm.nih.gov/sites/entrez/11481624
Kanzler S, Baumann M, Schirmacher P, Dries V, Bayer E, Gerken G, Dienes HP, Lohse AW:
Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-ß.
J Viral Hepatitis 2001; 8: 430 - 437
http://www.ncbi.nlm.nih.gov/sites/entrez/11703574
Kanzler S, Bozkurt S, Herkel J, Galle PR, Dienes HP, Lohse AW:
Bedeutung des Nachweises von SLA/LP Autoantikörpern bei Patienten mit primär biliärer Zirrhose.
Dtsch. Med. Wschr. 2001; 126: 450-456
Kanzler S, Galle PR, Meyer zum Büschenfelde KH, Lohse AW:
Long term management and prognosis of autoimmune hepatitis (AIH): a single centre experience.
Z Gastroenterol 2001; 39: 339-348
http://www.ncbi.nlm.nih.gov/sites/entrez/11413913
Kanzler S, Gerken G, Löhr H, Galle PR, Meyer zum Büschenfelde KH, Lohse AW:
Duration of immunosuppressive therapy in autoimmune hepatitis
J Hepatol 2001; 34: 354-355
http://www.ncbi.nlm.nih.gov/sites/entrez/11281572
Kanzler S, Meyer E, Lohse AW, Schirmacher P, Henninger J, Galle PR, Blessing M:
Hepatocellular expression of a dominant-negative mutant TGF-ß type II receptor accelerates chemically induced hepatocarcinogenesis.
Oncogene 2001; 20: 5015-24
http://www.ncbi.nlm.nih.gov/sites/entrez/11526486
Leifeld L, Ramakers J, Schneiders AM, Dumoulin FL, Sterneck M, Muller A, Sauerbruch T, Spengler U.:
Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis
Journal of Pathology 2001;194(4):478-483
http://www.ncbi.nlm.nih.gov/sites/entrez/11523057
Petersen J, Ott M, v. Weizsäcker F:
Zelltherapie in der Hepatologie - Aktueller Stand.
Z Gastroenterol 39:975-80 (2001).
http://www.ncbi.nlm.nih.gov/sites/entrez/11778158
Petersen J: Editorial zu 13. Grompe, M.
Mouse liver goes human: a new tool in experimental hepatology.
Hepatology 2001; 33:1005-1006
http://www.ncbi.nlm.nih.gov/sites/entrez/11283868
Piso P, Werner U, Benten D, Bektas H, Meuer U, Klempnauer J:
Early gastric cancer-excellent prognosis after curative resection in 87 patients irrespective of submucosal infiltration, lymph-node metastases or tumor size.
Langenbecks Arch Surg 2001; 386: 26-30
http://www.ncbi.nlm.nih.gov/sites/entrez/11405085
Rogiers, X, Meier, D, Sterneck, M, Broring, D.:
Medical-surgical evaluation of living liver donors.
Konkressband Deutsche Gesellschaft für Chirurgie 2001; 118: 248-52
Schramm C, Kanzler S, Galle PR, Meyer zum Büschenfelde KH, Lohse AW:
Autoimmune hepatitis in the elderly.
Am J Gastroenterol 2001; 96: 1587-1591
http://www.ncbi.nlm.nih.gov/sites/entrez/11374704
Sterneck M, Fischer L, Weise C, Broering D, Rogiers X.:
Steroid withdrawal in long-term liver transplant recipients
Transplantation Proceedings 2001;33(7-8):3265-3267
http://www.ncbi.nlm.nih.gov/sites/entrez/11750398
Törok E, Pollok JM, Ma PX, Kaufmann PM, Dandri M, Petersen J, Burda MR, Kluth D, Perner F, Rogiers X:
Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor.
Digestive Surgery 2001; 18:196-203
http://www.ncbi.nlm.nih.gov/sites/entrez/11464009
Törok E, Pollok JM, Ma PX, Vogel C, Dandri M, Petersen J, Burda MR, Kaufmann PM, Kluth D, Rogiers X:
Optimization of Hepatocyte Spheroid Formation for Hepatic Tissue Engineering on Three-Dimensional Biodegradable Polymer within a Flow Bioreactor prior to Implantation.
Cells Tissues Organs 2001; 169: 34-41
http://www.ncbi.nlm.nih.gov/sites/entrez/11340259
Wege H, Wu J, Santos RM, Zern MA:
Hepatocyte-based therapies for liver diseases - novel strategies and updates.
Journal Português de Gastroenterologia 2001; 8: 134-142
Wege H, Wu J, Zern MA:
Novel therapeutic modalities for hepatic diseases.
In: Okita K, ed. Frontiers in Hepatology/Liver Cirrhosis. Tokyo: Springer-Verlag, 2001. 17-29
Wu J, Lizarzaburu ME, Kurth MJ, Liu L, Wege H, Zern MA, Nantz MH.:
Cationic lipid polymerization as a novel approach for constructing new DNA delivery agents.
Bioconjugate Chemistry 2001;12:251-257.
http://www.ncbi.nlm.nih.gov/sites/entrez/11312686
Zöllner B, Petersen J, Schröter M, Laufs R, Feucht HH:
Twenty - fold increase in the risk of lamivudine resistance in Hepatitis B virus subtype adw.
Lancet 2001; 357: 934-35
http://www.ncbi.nlm.nih.gov/sites/entrez/11289355
Zöllner B, Petersen J, Schröter M, Laufs R, Feucht HH:
Correlation of hepatitis B virus load with loss of HBe antigen and emergence of drug - resistant variants during lamivudine therapy.
Journal of Medical Virology 2001; 65: 659-663
http://www.ncbi.nlm.nih.gov/sites/entrez/11745928
